This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Biography of Marie Annick Buendia
Introduction: Marie Annick Buendia is an accomplished inventor based in Le Perreux, France. She has made significant contributions to the field of medical diagnostics, particularly in the assessment of hepatocellular carcinoma (HCC).
Latest Patents: Marie Annick Buendia holds a patent for a diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC). This patent includes a method for detecting a predisposition to HCC using a unique panel of primers for identifying genetic alterations linked to the disease, as well as kits for carrying out these methods.
Career Highlights: Marie Annick Buendia is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she has been instrumental in advancing research in her field. Her work has garnered attention for its innovative approach to cancer diagnostics.
Collaborations: Throughout her career, Marie has collaborated with notable colleagues, including Anne Dejean and Pascal Pineau. These collaborations have further enriched her research and contributed to the development of effective diagnostic tools.
Conclusion: Marie Annick Buendia's contributions to medical diagnostics, particularly in the realm of hepatocellular carcinoma, highlight her role as a leading inventor in her field. Her innovative methods and collaborative efforts continue to impact the landscape of cancer research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile